Yueh‐Feng Wen

585 total citations
20 papers, 415 citations indexed

About

Yueh‐Feng Wen is a scholar working on Pulmonary and Respiratory Medicine, Molecular Biology and Radiology, Nuclear Medicine and Imaging. According to data from OpenAlex, Yueh‐Feng Wen has authored 20 papers receiving a total of 415 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Pulmonary and Respiratory Medicine, 5 papers in Molecular Biology and 3 papers in Radiology, Nuclear Medicine and Imaging. Recurrent topics in Yueh‐Feng Wen's work include Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Tracheal and airway disorders (5 papers). Yueh‐Feng Wen is often cited by papers focused on Lung Cancer Diagnosis and Treatment (9 papers), Lung Cancer Treatments and Mutations (6 papers) and Tracheal and airway disorders (5 papers). Yueh‐Feng Wen collaborates with scholars based in Taiwan, United States and Japan. Yueh‐Feng Wen's co-authors include Chong‐Jen Yu, Shang‐Gin Wu, Jin‐Yuan Shih, Yih‐Leong Chang, Pan‐Chyr Yang, James Chih‐Hsin Yang, Yinan Liu, Meng‐Feng Tsai, Ching‐Kai Lin and Lih‐Yu Chang and has published in prestigious journals such as Frontiers in Microbiology, Toxicology and Applied Pharmacology and Clinical Microbiology and Infection.

In The Last Decade

Yueh‐Feng Wen

20 papers receiving 412 citations

Peers

Countries citing papers authored by Yueh‐Feng Wen

Since Specialization

Citations

This map shows the geographic impact of Yueh‐Feng Wen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yueh‐Feng Wen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yueh‐Feng Wen more than expected).

Fields of papers citing papers by Yueh‐Feng Wen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yueh‐Feng Wen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yueh‐Feng Wen. The network helps show where Yueh‐Feng Wen may publish in the future.

Co-authorship network of co-authors of Yueh‐Feng Wen

This figure shows the co-authorship network connecting the top 25 collaborators of Yueh‐Feng Wen. A scholar is included among the top collaborators of Yueh‐Feng Wen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yueh‐Feng Wen. Yueh‐Feng Wen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Phase II Trial of LP-300 in Combination With Carboplatin and Pemetrexed in Never Smoker Patients With Relapsed Advanced Primary Adenocarcinoma of the Lung After Treatment With Tyrosine Kinase Inhibitors 2025 ·Clinical Lung Cancer ·J. Nicholas Bodor, Jonathan E. Dowell, Joseph Treat, Janakiraman Subramanian, (unknown), Eric Lee, Kamalesh K. Sankhala, (unknown), Go Makimoto, Eisaku Miyauchi, Kartik Konduri, Hajime Asahina, Shuji Murakami, Yueh‐Feng Wen, Yung‐Hung Luo, Sung‐Joon Chang, Reginald B. Ewesuedo, Jianli Zhou, (unknown)	1
2	Exploring the effects of pemetrexed on drug resistance mechanisms in human lung adenocarcinoma and its association with PGRMC1 2024 ·Chemico-Biological Interactions ·(unknown), En‐Chi Liao, Yueh‐Feng Wen, (unknown), (unknown), Hsiu‐Chuan Chou, Hong‐Lin Chan	1
3	Clinical utility and predictive value of cerebrospinal fluid cell-free DNA profiling in non-small cell lung cancer patients with leptomeningeal metastasis 2024 ·Neoplasia ·Sheng‐Kai Liang, Wei‐Yu Liao, Jin‐Yuan Shih, Chia‐Lin Hsu, Ching‐Yao Yang, Shang‐Gin Wu, Yen-Ting Lin, Yueh‐Feng Wen, (unknown), Yen‐Fu Chen, Ya‐Fang Chen, Yen‐Heng Lin, (unknown)	1
4	Incidence of and Risk Factors for Acute Kidney Injury During Antituberculosis Treatment: A Prospective Cohort Study and Literature Review 2023 ·Infectious Diseases and Therapy ·Chia‐Hao Chang, Lih‐Yu Chang, Jen‐Chung Ko, Yueh‐Feng Wen, (unknown), Li‐Ta Keng, (unknown), Kai‐Lun Yu, Jann‐Yuan Wang, Chong‐Jen Yu	7
5	Effectiveness of Endobronchial Ultrasound-Guided Transbronchial Biopsy Combined With Tissue Culture for the Diagnosis of Sputum Smear-Negative Pulmonary Tuberculosis 2022 ·Frontiers in Microbiology ·Ching‐Kai Lin, (unknown), Kai‐Lun Yu, Lih‐Yu Chang, Yueh‐Feng Wen, Li‐Ta Keng, Chao‐Chi Ho	3
6	Exploring Volatile Organic Compounds in Breath for High-Accuracy Prediction of Lung Cancer 2021 ·Cancers ·(unknown), (unknown), (unknown), (unknown), (unknown), Sheng‐Kai Liang, Yueh‐Feng Wen, Chia‐Hao Chang, Lih‐Yu Chang, Kai‐Lun Yu, (unknown), Li‐Ta Keng, Meng‐Rui Lee, Jen‐Chung Ko, Guan‐Hua Huang, Yaw‐Kuen Li	74
7	Cone-Beam Computed Tomography-Derived Augmented Fluoroscopy Improves the Diagnostic Yield of Endobronchial Ultrasound-Guided Transbronchial Biopsy for Peripheral Pulmonary Lesions 2021 ·Diagnostics ·Ching‐Kai Lin, (unknown), (unknown), Yen‐Ting Lin, Yueh‐Feng Wen, Shang‐Gin Wu, Chao‐Chi Ho	12
8	Treatment Options of First-Line Tyrosine Kinase Inhibitors and Subsequent Systemic Chemotherapy Agents for Advanced EGFR Mutant Lung Adenocarcinoma Patients: Implications From Taiwan Cancer Registry Cohort 2021 ·Frontiers in Oncology ·Sheng‐Kai Liang, Li‐Ta Keng, Chia‐Hao Chang, Yueh‐Feng Wen, Meng‐Rui Lee, Ching‐Yao Yang, Jann‐Yuan Wang, Jen‐Chung Ko, Jin‐Yuan Shih, Chong‐Jen Yu	5
9	Functional Status After Pulmonary Rehabilitation as a Predictor of Weaning Success and Survival in Patients Requiring Prolonged Mechanical Ventilation 2021 ·Frontiers in Medicine ·Li‐Ta Keng, Sheng‐Kai Liang, (unknown), Yueh‐Feng Wen, (unknown), Chia‐Hao Chang, Lih‐Yu Chang, Kai‐Lun Yu, Meng‐Rui Lee, Jen‐Chung Ko	3
10	Effectiveness of convolutional neural networks in the interpretation of pulmonary cytologic images in endobronchial ultrasound procedures 2021 ·Cancer Medicine ·Ching‐Kai Lin, (unknown), Ching‐Chun Huang, Yueh‐Feng Wen, Chao‐Chi Ho, (unknown)	13
11	Rapid on-site cytologic evaluation by pulmonologist improved diagnostic accuracy of endobronchial ultrasound-guided transbronchial biopsy 2020 ·Journal of the Formosan Medical Association ·Ching‐Kai Lin, I‐Shiow Jan, Kai‐Lun Yu, Lih‐Yu Chang, (unknown), Yueh‐Feng Wen, Chao‐Chi Ho	18
12	Differentiating metastatic lymph nodes in lung cancer patients based on endobronchial ultrasonography features 2018 ·Medical Ultrasonography ·Ching‐Kai Lin, Lih‐Yu Chang, Kai‐Lun Yu, Yueh‐Feng Wen, (unknown), Chao‐Chi Ho	9
13	Differentiating malignant and benign lymph nodes using endobronchial ultrasound elastography 2018 ·Journal of the Formosan Medical Association ·Ching‐Kai Lin, Kai‐Lun Yu, Lih‐Yu Chang, (unknown), Yueh‐Feng Wen, Chao‐Chi Ho	25
14	Learning curve and advantages of endobronchial ultrasound‐guided transbronchial needle aspiration as a first‐line diagnostic and staging procedure 2017 ·Thoracic Cancer ·Ching‐Kai Lin, Chao‐Lun Lai, Lih‐Yu Chang, Yueh‐Feng Wen, Chao‐Chi Ho	9
15	The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patients 2016 ·Oncotarget ·Shang‐Gin Wu, Yinan Liu, Meng‐Feng Tsai, Yih‐Leong Chang, Chong‐Jen Yu, Pan‐Chyr Yang, James Chih‐Hsin Yang, Yueh‐Feng Wen, Jin‐Yuan Shih	192
16	Identification of protein expression alterations in gefitinib-resistant human lung adenocarcinoma: PCNT and mPR play key roles in the development of gefitinib-associated resistance 2015 ·Toxicology and Applied Pharmacology ·Chi‐Chen Lin, (unknown), Meng‐Wei Lin, Chia‐Hao Chan, Yueh‐Feng Wen, (unknown), (unknown), (unknown), Hsiu‐Chuan Chou, Hong‐Lin Chan	6
17	Identification of Up- and Down-Regulated Proteins in Pemetrexed-Resistant Human Lung Adenocarcinoma: Flavin Reductase and Calreticulin Play Key Roles in the Development of Pemetrexed-Associated Resistance 2015 ·Journal of Proteome Research ·Hsiu‐Chuan Chou, Jingyi Chen, (unknown), Yueh‐Feng Wen, Chi‐Chen Lin, Sheng‐Hao Lin, Ching‐Hsiung Lin, (unknown), En‐Chi Liao, Ying‐Jen Chen, Yushan Wei, Yi‐Ting Tsai, Hong‐Lin Chan	10
18	Factors associated with subsequent nontuberculous mycobacterial lung disease in patients with a single sputum isolate on initial examination 2014 ·Clinical Microbiology and Infection ·Meng‐Rui Lee, Chung‐Yi Yang, Chin‐Chung Shu, Ching‐Kai Lin, Yueh‐Feng Wen, (unknown), Jen‐Chung Ko, Jann‐Yuan Wang, Li‐Na Lee, Chong‐Jen Yu	18
19	Proteomic and redox‐proteomic study on the role of glutathione reductase in human lung cancer cells 2013 ·Electrophoresis ·(unknown), Hsiu‐Chuan Chou, (unknown), Yueh‐Feng Wen, (unknown), Haimei Huang, Hong‐Lin Chan	7
20	Unusual Discrepancy Between S _{pO ₂} and S _{aO ₂} in a 31-Year-Old Man With Chronic Myelogenous Leukemia 2012 ·Respiratory Care ·Yueh‐Feng Wen, Ping‐Hung Kuo	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact